Literature DB >> 7524234

Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands.

L S Marks1, B Treiger, F J Dorey, Y S Fu, J B deKernion.   

Abstract

OBJECTIVES: Morphometry, or quantitative image analysis, offers great promise in characterizing the various histologic types of benign prostatic hyperplasia (BPH), but to date, a systematic study of the tissue components is lacking. Thus we employed morphometry to examine the distribution of primary BPH tissues throughout whole human prostates.
METHODS: The prostate glands of 20 men with BPH were removed for low-volume carcinoma and subjected to a uniform, comprehensive, systematic quantification of the primary BPH tissue components using the technique of digitization and point-count morphometry.
RESULTS: We found the following average volumes among the 20 glands: epithelium, 19.9% (S.D. 5.1%, range 11.7% to 30.8%); fibromuscular stroma, 50.4% (S.D. 9.4%, range 32.2% to 74.4%); glandular lumina, 29.7% (S.D. 8.9%, range 11.9% to 47.5%). Within the individual prostates, we found symmetry in primary BPH tissue distribution, except that the outer prostate was on average 25% richer in epithelium than the inner prostate (p < 0.05). When tissue composition was determined in simulated biopsy specimens, corrected for radial (ie, inner vs outer gland) orientation, the correlation with whole-organ composition was statistically significant for "percentage epithelium" (r = 0.72, p < 0.01) and for "stromal/epithelial ratio" (r = 0.63, p < 0.01).
CONCLUSIONS: Major differences in primary tissue composition may separate different hyperplastic prostates. Primary BPH tissues are rather symmetrically distributed within individual prostates. Quantitative histologic differences between prostates, potentially important in clinical decision-making may be accurately diagnosed by morphometry of radially oriented biopsy specimens.

Entities:  

Mesh:

Year:  1994        PMID: 7524234     DOI: 10.1016/s0090-4295(94)80044-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  MR measurement of luminal water in prostate gland: Quantitative correlation between MRI and histology.

Authors:  Shirin Sabouri; Ladan Fazli; Silvia D Chang; Richard Savdie; Edward C Jones; S Larry Goldenberg; Peter C Black; Piotr Kozlowski
Journal:  J Magn Reson Imaging       Date:  2017-01-27       Impact factor: 4.813

Review 2.  Targeting phenotypic heterogeneity in benign prostatic hyperplasia.

Authors:  Douglas W Strand; Daniel N Costa; Franto Francis; William A Ricke; Claus G Roehrborn
Journal:  Differentiation       Date:  2017-08-04       Impact factor: 3.880

3.  Magnetic resonance imaging of benign prostatic hyperplasia.

Authors:  Serkan Guneyli; Emily Ward; Stephen Thomas; Ambereen Nehal Yousuf; Igor Trilisky; Yahui Peng; Tatjana Antic; Aytekin Oto
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

4.  Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer.

Authors:  Benjamin A Rybicki; Sudha M Sadasivan; Yalei Chen; Ian Loveless; Nilesh S Gupta; Dhananjay A Chitale; Sean R Williamson; Andrew G Rundle; Deliang L Tang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-05-04       Impact factor: 4.090

5.  Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia.

Authors:  Martella Oreste; Paradiso Galatioto Giuseppe; Pace Gianna; Angelucci Adriano; Necozione Stefano; Bologna Mauro; Vicentini Carlo
Journal:  World J Urol       Date:  2009-08-19       Impact factor: 4.226

6.  Distinct function of estrogen receptor α in smooth muscle and fibroblast cells in prostate development.

Authors:  Spencer Vitkus; Chiuan-Ren Yeh; Hsiu-Hsia Lin; Iawen Hsu; Jiangzhou Yu; Ming Chen; Shuyuan Yeh
Journal:  Mol Endocrinol       Date:  2012-11-30

7.  Prostate specific antigen and acinar density: a new dimension, the "Prostatocrit".

Authors:  Simon Robinson; Marc Laniado; Bruce Montgomery
Journal:  Int Braz J Urol       Date:  2017 Mar-Apr       Impact factor: 1.541

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.